Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Apogee Therapeutics, Inc. is a clinical-stage biotechnology company developing novel biologic therapies for inflammatory and immunology (I&I) diseases such as atopic dermatitis, asthma, eosinophilic esophagitis, and COPD. Its pipeline features engineered monoclonal antibodies with extended half-life modifications targeting IL-13, OX40L, TSLP, and IL-4Rα. Apogee aims to improve efficacy and reduce dosing frequency, addressing unmet needs through optimized antibody design and combination therapies.
This description was generated via AI from an annual report. Updated about 1 year ago.